Categories: aggregated

Pharmaceutical Companies Win Big with Schedule 3 Classification of Cannabis – Desheduling is the Only Way for True Equity

For decades, Joe Biden has been cozy with Big Pharma, accepting millions in campaign contributions from drug companies over his long political career. It’s no secret that the pharmaceutical industry vehemently opposes cannabis legalization, as legal weed represents a major threat to their profits from opiate painkillers and other drugs. Pharma much prefers that cannabis remain illegal, or barring that, placed into a restrictive category like Schedule III that they can control and corner the market on.

Jason

Share
Published by
Jason

Recent Posts

Experience CannaLand, the one-of-a-kind celebration presented by Deep Stories

Get ready for Deep Stories’ CannaLand! Arizona’s premier one-day cannabis festival begins 11 a.m. on…

22 hours ago

Why Quitting Alcohol or Weed Won’t Heal the Pain That Caused You to Start Using Them in the First Place

They sit in circles, eyes gleaming with hope as they declare, "If I could only…

3 days ago

The Cannabis Rescheduling Ruse – White House Says No Action Planned on Cannabis Reform, Hate to Say I Told You So!

In a move that surprised absolutely no one who's been paying attention, the White House…

3 days ago

Former New York Knick Iman Shumpert debuts legal cannabis brand with Glenmere Farms

The NBA champion and New York Knick will premier his new flower brand at Torches…

5 days ago

How New York pot pioneers made it to legal dispensary shelves

By: LMC Legacy to licensed is the motto for authentic New York brands entering the…

5 days ago

Vladimir Bautista is leading Happy Munkey’s legacy-to-legal takeover

Vlad Bautista began his cannabis empire in Harlem's Sugar Hill. Nearly 30 years later, his…

5 days ago